ADVFN Logo ADVFN

Hot Features

Registration Strip Icon for charts 登録してリアルタイムのチャート、分析ツール、価格を入手してください。

NXTC NextCure Inc

1.48
-0.01 (-0.67%)
2024年5月4日 - 終了
15分遅延
名称 銘柄コード 市場 種別
NextCure Inc NXTC NASDAQ 普通株式
  前日比 前日比 % 現在値 時刻
-0.01 -0.67% 1.48 09:00:00
始値 安値 高値 終値 前日終値
1.60 1.49 1.60 1.53 1.49
この銘柄の詳細情報 »

最新ニュース

日付 時間 ソース タイトル
2024/5/0305:05GLOBENextCure Provides Business Update and Reports First Quarter..
2024/4/2505:05GLOBENextCure to Present Phase 1b Data of NC410 in Combination..
2024/4/0820:00GLOBENextCure and LCB Present Preclinical Data on B7-H4 Antibody..
2024/4/0420:05GLOBENextCure Appoints Dr. Rakesh Dixit to Scientific Advisory..
2024/4/0220:00GLOBENextCure to Present at 23rd Annual Needham Virtual..
2024/3/2121:55GLOBENextCure Provides Business Update and Reports Full Year 2023..
2024/3/0522:05GLOBENextCure Publishes Preclinical Data Demonstrating Function..
2024/2/0206:45EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/2/0206:45EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/2/0206:44EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/2/0206:44EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/2/0206:43EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/2/0206:43EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/1/1906:05GLOBENextCure Presents Preclinical Data on a Novel Therapeutic..
2023/12/2121:05GLOBENextCure Publishes Non-Clinical Data Demonstrating..
2023/12/1421:15EDGAR2Form 8-K - Current report
2023/12/1420:45GLOBENextCure Provides Year-End Clinical Pipeline Updates
2023/11/2021:00GLOBENextCure to Present at the 35th Annual Piper Sandler..
2023/11/1606:05GLOBENextCure Publishes Non-Clinical Data Defining the Mechanism..
2023/11/0305:20EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2023/11/0305:10EDGAR2Form 8-K - Current report
2023/11/0305:05GLOBENextCure Provides Business Update and Reports Third Quarter..
2023/10/1721:05GLOBEPreclinical Data Demonstrate Anti-Siglec-15 Treatment..
2023/9/2705:05GLOBENextCure Presents Preclinical Data on NC181, a Novel..
2023/9/1221:05GLOBEA Phase 2 Study of Anti-Siglec-15 Antibody, NC318, in..
2023/9/0805:05GLOBENextCure and Nordic Bioscience Publish Review Article on the..
2023/9/0605:05GLOBEPreclinical Data Demonstrate Potential Application of..
2023/8/3120:00GLOBENextCure to Present at the H.C. Wainwright 25th Annual..
2023/8/0505:58EDGAR2Form S-8 - Securities to be offered to employees in employee..
2023/8/0505:30EDGAR2Form S-3 - Registration statement under Securities Act of..
2023/8/0405:26EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2023/8/0405:16EDGAR2Form 8-K - Current report
2023/8/0405:05GLOBENextCure Provides Business Update and Reports Second Quarter..
2023/7/2005:05EDGAR2Form 8-K - Current report
2023/6/2205:05GLOBENextCure Presents Non-Clinical Data Defining the Mechanism..
2023/5/0920:00GLOBENextCure to Present at the JMP Securities Life Sciences..

最近閲覧した銘柄

Delayed Upgrade Clock